Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()

Dysregulation of S100A8 is described in many different human tumor types, but its role in prostate cancer is unknown. To evaluate the clinical relevance of S100A8 expression in prostate cancer, a tissue microarray containing 13,665 tumors was analyzed by immunohistochemistry. Cytoplasmic S100A8 stai...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Neoplasia
Main Authors: Minner, Sarah, Hager, Dominik, Steurer, Stefan, Höflmayer, Doris, Tsourlakis, Maria Christina, Möller-Koop, Christina, Clauditz, Till S, Hube-Magg, Claudia, Luebke, Andreas M, Simon, Ronald, Sauter, Guido, Göbel, Cosima, Weidemann, Sören, Lebok, Patrick, Dum, David, Fraune, Christoph, Izbicki, Jakob, Burandt, Eike, Schlomm, Thorsten, Huland, Hartwig, Heinzer, Hans, Haese, Alexander, Graefen, Markus, Heumann, Asmus
פורמט: Artigo
שפה:Inglês
יצא לאור: Neoplasia Press 2019
נושאים:
Original article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6698296/
https://ncbi.nlm.nih.gov/pubmed/31382165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2019.07.003
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים